Corbus Pharmaceuticals Financial Overview
Corbus Pharmaceuticals's market cap is currently $152.01M. The company's EPS TTM is $-1.9; its P/E ratio is -1.48; Corbus Pharmaceuticals is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-1.54. See an overview of income statement, balance sheet, and cash flow financials.
